Gene therapy for laryngeal paralysis

Annals of Otology, Rhinology and Laryngology

Volumn 116, Issue 2, 2007, Pages 115-122

  Shiotani, Akihiro ^a,b   Saito, Koichiro ^b   Araki, Koji ^b   Moro, Kazuhisa ^b   Watabe, Kazuhiko ^c  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

BDNF; Brain derived neurotrophic factor; Functional recovery; GDNF; Gene therapy; Glial cell line derived neurotrophic factor; Motoneuron loss; Nerve conduction velocity

Indexed keywords

ADENOVIRUS VECTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

AMBIGUUS NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVULSION INJURY; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; CRUSH TRAUMA; DRUG SAFETY; GENE THERAPY; GENE TRANSFER; LARYNX; MOTONEURON; NERVE CONDUCTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT LARYNGEAL NERVE PALSY; VAGUS NERVE; VOCAL CORD;

EID: 33847316167     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940711600207     Document Type: Article

References (31)

1. Li L, Oppenheim RW, Lei M, Houenou LJ Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. J Neurobiol 1994;25:759-66.
2. Shiotani A, O'Malley BW Jr, Coleman ME, Alila HW, Flint PW. Reinnervation of motor endplates and increased muscle fiber size after human insulin-like growth factor I gene transfer into the paralyzed larynx. Hum Gene Ther 1998;9:2039-47.
3. Flint PW, Shiotani A, O'Malley BW Jr. IGF-1 gene transfer into denervated rat laryngeal muscle. Arch Otolaryngol Head Neck Surg 1999;125:274-9.
4. Shiotani A, O'Malley BW Jr, Coleman ME, Flint PW. Human insulinlike growth factor 1 gene transfer into paralyzed rat larynx: single vs multiple injection. Arch Otolaryngol Head Neck Surg 1999;125:555-60.
5. Nakagawa H, Shiotani A, O'Malley BW Jr, Coleman ME, Flint PW Timing of human insulin-like growth factor-1 gene transfer in reinnervating laryngeal muscle. Laryngoscope 2004;114:726-32.
6. Flint PW, Nakagawa H, Shiotani A, Coleman ME, O'Malley BW Jr. Effects of insulin-like growth factor-1 gene transfer on myosin heavy chains in denervated rat laryngeal muscle. Laryngoscope 2004;114:368-71.
7. Henderson CE, Phillips HS, Pollock RA, et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994;266:1062-4. [Erratum in Science 1995;267:777.]
8. Li L, Wu W, Lin LF, Lei M, Oppenheim RW, Houenou LJ. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc Natl Acad Sci U S A 1995;92:9771-5.
9. Yan Q, Matheson C, Lopez OT. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 1995;373:341-4.
10. Sakamoto T, Watabe K, Ohashi T, et al. Adenoviral vec-tor-mediated GDNF gene transfer prevents death of adult facial motoneurons. Neuroreport 2000;11:1857-60.
11. Nguyen QT, Parsadanian AS, Snider WD, Lichtman JW. Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science 1998;279:1725-9.
12. Hoke A, Cheng C, Zochodne DW. Expression of glial cell line-derived neurotrophic factor family of growth factors in peripheral nerve injury in rats. Neuroreport 2000;11:1651-4.
13. Friedman WJ, Greene LA. Neurotrophin signaling via Trks and p75. Exp Cell Res 1999;253:131-42.
14. Yano H, Chao MV. Neurotrophin receptor structure and interactions. Pharm Acta Helv 2000;74:253-60.
15. Kishino A, Ishige Y, Tatsuno T, Nakayama C, Noguchi H. BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth. Exp Neurol 1997;144:273-86.
16. Oppenheim RW, Houenou LJ, Johnson JE, et al. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 1995;373:344-6.
17. Chai H, Wu W, So KF, Prevette DM, Oppenheim RW. Long-term effects of a single dose of brain-derived neurotrophic factor on motoneuron survival following spinal root avulsion in the adult rat. Neurosci Lett 1999;274:147-50.
18. Blits B, Carlstedt TP, Ruitenberg MJ, et al. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor. Exp Neurol 2004;189:303-16.
19. Saito K, Shiotani A, Watabe K, Moro K, Fukuda H, Ogawa K. Adenoviral GDNF gene transfer prevents motoneuron loss in the nucleus ambiguus. Brain Res 2003;962:61-7.
20. Hangai K, Enomoto K, Kobayashi Y. Postnatal develop-ment of intrinsic laryngeal muscles and motoneurons of the nucleus ambiguus in rats. Larynx 1995;7:133-8.
21. Moro K, Shiotani A, Watabe K, et al. Adenoviral gene transfer of BDNF and GDNF synergistically prevent motoneuron loss in the nucleus ambiguus. Brain Res 2006;1076:1-8.
22. Araki K, Shiotani A, Watabe K, Saito K, Moro K, Ogawa K. Adenoviral GDNF gene transfer enhances neurofunctional recovery after recurrent laryngeal nerve injury. Gene Ther 2006;13:296-303.
23. Baumgartner BJ, Shine HD. Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor. Exp Neurol 1998;153:102-12.
24. Chen ZY, Chai YF, Cao L, Lu CL, He C. Glial cell line-derived neurotrophic factor enhances axonal regeneration following sciatic nerve transection in adult rats. Brain Res 2001;902:272-6.
25. Varejao AS, Cabrita AM, Meek MF, et al. Functional and morphological assessment of a standardized rat sciatic nerve crush injury with a non-serrated clamp. J Neurotrauma 2004;21:1652-70.
26. Bridge PM, Ball DJ, Mackinnon SE, et al. Nerve crush injuries -a model for axonotmesis. Exp Neurol 1994;127:284-90.
27. Zeng L, Worseg A, Albrecht G, et al. A noninvasive functional evaluation following peripheral nerve repair with electromyography in a rat model. Plast Reconstr Surg 1994;94:146-51.
28. George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003;10:1135-4l.
29. Check E, Sanctions agreed over teenager's gene-therapy death. Nature 2005;433:674.
30. Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003;80:148-58.
31. Shiotani A, Fukumura M, Maeda M, et al Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector. Gene Ther 2001;8:1043-50.